3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
3
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Conditions
Lung Neoplasms
10
Small Cell Lung Carcinoma
9
Mesothelioma, Malignant
7
Carcinoma, Non-Small-Cell Lung
5
Neoplasm Metastasis
4
Sarcoma
3
Thymoma
2
Ovarian Neoplasms
2
Neoplasms
2
Mesothelioma
2
Lymphoma, Non-Hodgkin
2
Head and Neck Neoplasms
2
Glioma
2
Fallopian Tube Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Breast Neoplasms
2
Waldenstrom Macroglobulinemia
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Thymic epithelial tumor
1
Stomach Neoplasms
1
Sezary Syndrome
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
pembrolizumab
6
Gemcitabine
6
Psychiatric Rehabilitation
5
Early Intervention, Educational
5
Cisplatin
5
Cetuximab
5
cediranib
4
Oxaliplatin
4
Magnetic Resonance Spectroscopy
4
Leucovorin
4
Fluorouracil
4
Carboplatin
4
Bevacizumab
4
Trastuzumab
3
Standard of Care
3
Radiotherapy
3
Pemetrexed
3
Paclitaxel
3
Methods
3
Irinotecan
3
Erlotinib Hydrochloride
3
Docetaxel
3
trametinib
2
X-Rays
2
Specimen Handling
2
Mental Status and Dementia Tests
2
Interleukin-12 Subunit p35
2
Fluorodeoxyglucose F18
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Rectal Neoplasms
×
Doxorubicin
×
Thoracic
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled